Indira IVF forays into diagnostic business with ‘Indira Pathlabs’
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
36.4% of patients with diabetic neuropathic pain in 2021 were completely treatment refractory and would benefit from new treatment options.
Dr. Lal Path Labs has reported total income of Rs. 511 crores during the period ended June 30, 2022
OS-SiA is the industry’s first AI-enabled digital scanner that will provide real-time predictive analysis and actionable insights
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
A primary investment of Rs 194.4 crore has been made
A post approval change order is often necessary, but innovators should plan and prepare for this pre-approval. Planning alongside outsourcing partners will help ensure that only a small-scale study is needed—not a new full clinical study
Potential new treatment for progressive pulmonary fibrosis (PPF) builds on Boehringer Ingelheim’s leadership in lung fibrosis and will be further investigated in a phase III clinical trial program
Dr. Kalyan Banerjee's Clinic developed a homeopathy prophylaxis protocol for the prevention of Covid-19 as soon as the pandemic began
Subscribe To Our Newsletter & Stay Updated